SG Americas Securities’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.62M | Sell |
8,731
-3,648
| -29% | -$1.68M | ﹤0.01% | 1127 |
|
|
2026
Q1 | $5.94M | Sell |
12,379
-47,765
| -79% | -$24.5M | 0.01% | 986 |
|
|
2025
Q4 | $33.8M | Buy |
60,144
+54,014
| +881% | +$30.7M | 0.04% | 325 |
|
|
2025
Q3 | $3.15M | Buy |
6,130
+5,202
| +561% | +$2.27M | 0.01% | 713 |
|
|
2025
Q2 | $291K | Sell |
928
-2,373
| -72% | -$712K | ﹤0.01% | 2024 |
|
|
2025
Q1 | $1.01M | Sell |
3,301
-21,292
| -87% | -$7.16M | ﹤0.01% | 1172 |
|
|
2024
Q4 | $8.17M | Buy |
24,593
+22,289
| +967% | +$7.56M | 0.03% | 254 |
|
|
2024
Q3 | $769K | Sell |
2,304
-11,565
| -83% | -$4.39M | ﹤0.01% | 1300 |
|
|
2024
Q2 | $5.71M | Sell |
13,869
-1,133
| -8% | -$449K | 0.03% | 493 |
|
|
2024
Q1 | $6.06M | Buy |
15,002
+11,679
| +351% | +$4.11M | 0.03% | 485 |
|
|
2023
Q4 | $1.02M | Buy |
3,323
+808
| +32% | +$218K | 0.01% | 1013 |
|
|
2023
Q3 | $609K | Buy |
2,515
+1,960
| +353% | +$501K | 0.01% | 1614 |
|
|
2023
Q2 | $133K | Sell |
555
-6,880
| -93% | -$1.43M | ﹤0.01% | 1965 |
|
|
2023
Q1 | $1.4M | Sell |
7,435
-76
| -1% | -$15.7K | 0.02% | 895 |
|
|
2022
Q4 | $1.59M | Sell |
7,511
-587
| -7% | -$117K | 0.02% | 671 |
|
|
2022
Q3 | $1.27M | Sell |
8,098
-1,012
| -11% | -$161K | 0.02% | 859 |
|
|
2022
Q2 | $1.36M | Buy |
9,110
+474
| +5% | +$68.6K | 0.01% | 1023 |
|
|
2022
Q1 | $1.41M | Sell |
8,636
-4,279
| -33% | -$706K | 0.01% | 1170 |
|
|
2021
Q4 | $2.81M | Sell |
12,915
-10,319
| -44% | -$2.16M | 0.02% | 829 |
|
|
2021
Q3 | $4.4M | Buy |
23,234
+8,852
| +62% | +$1.61M | 0.02% | 625 |
|
|
2021
Q2 | $2.54M | Buy |
14,382
+671
| +5% | +$116K | 0.01% | 981 |
|
|
2021
Q1 | $2.25M | Buy |
13,711
+755
| +6% | +$115K | 0.01% | 971 |
|
|
2020
Q4 | $1.8M | Sell |
12,956
-2,190
| -14% | -$276K | 0.01% | 1153 |
|
|
2020
Q3 | $1.69M | Sell |
15,146
-10,769
| -42% | -$1.25M | 0.01% | 847 |
|
|
2020
Q2 | $2.41M | Buy |
25,915
+10,379
| +67% | +$883K | 0.02% | 705 |
|
|
2020
Q1 | $1.14M | Buy |
15,536
+10,579
| +213% | +$918K | 0.01% | 1204 |
|
|
2019
Q4 | $417K | Sell |
4,957
-24,751
| -83% | -$1.92M | ﹤0.01% | 1924 |
|
|
2019
Q3 | $2.5M | Buy |
29,708
+15,464
| +109% | +$1.17M | 0.02% | 811 |
|
|
2019
Q2 | $932K | Buy |
14,244
+7,973
| +127% | +$459K | 0.01% | 1478 |
|
|
2019
Q1 | $370K | Buy |
6,271
+2,230
| +55% | +$133K | ﹤0.01% | 2099 |
|
|
2018
Q4 | $214K | Buy |
4,041
+2,008
| +99% | +$110K | ﹤0.01% | 2351 |
|
|
2018
Q3 | $122K | Sell |
2,033
-448
| -18% | -$24.5K | ﹤0.01% | 2792 |
|
|
2018
Q2 | $107K | Buy |
+2,481
| New | +$100K | ﹤0.01% | 3029 |
|
|
2018
Q1 | – | Sell |
-4,167
| Closed | -$151K | – | 3434 |
|
|
2017
Q4 | $151K | Buy |
+4,167
| New | +$146K | ﹤0.01% | 2629 |
|
Other funds holding MEDP
WA
SG Americas Securities's MEDP Position: Q2 2026 in Review
SG Americas Securities reduced its Medpace (MEDP) stake by 29% in Q2 2026, selling an estimated $1.68M and leaving 8,731 shares worth $4.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1127.
SG Americas Securities first reported a position in MEDP in Q4 2017 and has held it in 34 quarters since. The position peaked at $33.8M in Q4 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- SG Americas Securities held 8,731 shares of Medpace worth $4.62M as of Q2 2026.
- SG Americas Securities sold 3,648 Medpace shares in Q2 2026, an estimated $1.68M.
- Medpace made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1127 holding.
- SG Americas Securities first reported a position in Medpace in Q4 2017 and has held it in 34 quarters since.
- SG Americas Securities's Medpace position peaked at $33.8M in Q4 2025.
- 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.